Finasteride 1mg

Description

Finasteride 1mg is the established pharmaceutical standard for managing DHT-related androgenic side effects — targeting 5-alpha reductase type II to reduce serum DHT by approximately 65–70%. At 1mg, this is the clinically proven dose for androgenic alopecia (hairloss prevention), making it the go-to compound for testosterone users who want to protect their hair on cycle and off. Finasteride works upstream, blocking the conversion of testosterone to dihydrotestosterone in scalp, skin, and prostate tissue — reducing the androgenic load that drives miniaturisation of hair follicles and prostate enlargement. At this dose, the systemic DHT reduction is significant but not total, preserving some DHT activity (which matters for mood, libido, and erectile function). For those requiring deeper suppression or running higher-DHT cycles, Dutasteride should be considered. Phalanx’s Finasteride is verified at 99%+ purity by Puralytix — pharmaceutical quality without pharmaceutical markup. Daily administration is required for consistent DHT suppression — the compound’s half-life is 6 hours, making once-daily consistent timing important for stable plasma levels. Significant hair protection effect typically begins expressing at 3–6 months of consistent use, with clinical data showing 83% of men experiencing maintained or improved hair count at 2 years. A fundamental stack addition for testosterone-sensitive users.